Literature DB >> 3543939

Desferrioxamine suppresses Plasmodium falciparum in Aotus monkeys.

S Pollack, R N Rossan, D E Davidson, A Escajadillo.   

Abstract

Clinical observation has suggested that iron deficiency may be protective in malaria, and we have found that desferrioxamine (DF), an iron-specific chelating agent, inhibited Plasmodium falciparum growth in vitro. It was difficult to be confident that DF would be effective in an intact animal, however, because continuous exposure to DF was required in vitro and, in vivo, DF is rapidly excreted. Also, the in vitro effect of DF was overcome by addition of iron to the culture and in vivo there are potentially high local iron concentrations when iron is absorbed from the diet or released from reticuloendothelial cells. We now show that DF given by constant subcutaneous infusion does suppress parasitemia in P. falciparum-infected Aotus monkeys.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3543939     DOI: 10.3181/00379727-184-42461

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN: 0037-9727


  23 in total

1.  In vitro potentiation of antibiotic activities by a catecholate iron chelator against chloroquine-resistant Plasmodium falciparum.

Authors:  Bruno Pradines; Florence Ramiandrasoa; Jean Marc Rolain; Christophe Rogier; Joel Mosnier; William Daries; Thierry Fusai; Gerhard Kunesch; Jacques Le Bras; Daniel Parzy
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  In vivo expression of in vitro anticoccidial activity.

Authors:  A P Ricketts; J A Olson; J R Rice
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

Review 3.  Siderophore-based iron acquisition and pathogen control.

Authors:  Marcus Miethke; Mohamed A Marahiel
Journal:  Microbiol Mol Biol Rev       Date:  2007-09       Impact factor: 11.056

4.  Influence of nutritional and haemoglobin status on malaria infection in children.

Authors:  S K Ghosh; R S Yadav; B S Das; V P Sharma
Journal:  Indian J Pediatr       Date:  1995 May-Jun       Impact factor: 1.967

5.  In vitro activities of novel catecholate siderophores against Plasmodium falciparum.

Authors:  B Pradines; F Ramiandrasoa; L K Basco; L Bricard; G Kunesch; J Le Bras
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 6.  The role of antioxidants treatment on the pathogenesis of malarial infections: a review.

Authors:  Murtala Bindawa Isah; Mohammed Auwal Ibrahim
Journal:  Parasitol Res       Date:  2014-02-13       Impact factor: 2.289

7.  Chemical Determinants of antimalarial activity of reversed siderophores.

Authors:  A Tsafack; J Libman; A Shanzer; Z I Cabantchik
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 8.  Oxidative stress in malaria; implications for prevention and therapy.

Authors:  N S Postma; E C Mommers; W M Eling; J Zuidema
Journal:  Pharm World Sci       Date:  1996-08

9.  Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.

Authors:  J Golenser; A Tsafack; Y Amichai; J Libman; A Shanzer; Z I Cabantchik
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

10.  Erythroferrone contributes to hepcidin repression in a mouse model of malarial anemia.

Authors:  Chloé Latour; Myriam F Wlodarczyk; Grace Jung; Aurélie Gineste; Nicolas Blanchard; Tomas Ganz; Marie-Paule Roth; Hélène Coppin; Léon Kautz
Journal:  Haematologica       Date:  2016-09-22       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.